Precipio Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.284
- Today's High:
- $0.31
- Open Price:
- $0.284
- 52W Low:
- $0.28
- 52W High:
- $1.26
- Prev. Close:
- $0.284
- Volume:
- 97371
Company Statistics
- Market Cap.:
- $7.83 million
- Book Value:
- 0.509
- Revenue TTM:
- $10.96 million
- Operating Margin TTM:
- -99.24%
- Gross Profit TTM:
- $2.39 million
- Profit Margin:
- -98.5%
- Return on Assets TTM:
- -29.9%
- Return on Equity TTM:
- -62.21%
Company Profile
Precipio Inc had its IPO on 2000-07-18 under the ticker symbol PRPO.
The company operates in the Healthcare sector and Diagnostics & Research industry. Precipio Inc has a staff strength of 53 employees.
Stock update
Shares of Precipio Inc opened at $0.28 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.28 - $0.31, and closed at $0.3.
This is a +3.87% increase from the previous day's closing price.
A total volume of 97,371 shares were traded at the close of the day’s session.
In the last one week, shares of Precipio Inc have slipped by -11.41%.
Precipio Inc's Key Ratios
Precipio Inc has a market cap of $7.83 million, indicating a price to book ratio of 0.8422 and a price to sales ratio of 1.4963.
In the last 12-months Precipio Inc’s revenue was $10.96 million with a gross profit of $2.39 million and an EBITDA of $-9547000. The EBITDA ratio measures Precipio Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Precipio Inc’s operating margin was -99.24% while its return on assets stood at -29.9% with a return of equity of -62.21%.
In Q2, Precipio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 49.8%.
Precipio Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.46 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Precipio Inc’s profitability.
Precipio Inc stock is trading at a EV to sales ratio of 1.2441 and a EV to EBITDA ratio of -1.1167. Its price to sales ratio in the trailing 12-months stood at 1.4963.
Precipio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $19.47 million
- Total Liabilities
- $4.72 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $32000
- Dividend Payout Ratio
- 0%
Precipio Inc ended 2024 with $19.47 million in total assets and $0 in total liabilities. Its intangible assets were valued at $19.47 million while shareholder equity stood at $14.03 million.
Precipio Inc ended 2024 with $0 in deferred long-term liabilities, $4.72 million in other current liabilities, 275000.00 in common stock, $-97620000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $2.57 million and cash and short-term investments were $2.57 million. The company’s total short-term debt was $407,000 while long-term debt stood at $120000.00.
Precipio Inc’s total current assets stands at $4.35 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $884000.00 compared to accounts payable of $2.40 million and inventory worth $537000.00.
In 2024, Precipio Inc's operating cash flow was $0 while its capital expenditure stood at $32000.
Comparatively, Precipio Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.3
- 52-Week High
- $1.26
- 52-Week Low
- $0.28
- Analyst Target Price
- $2
Precipio Inc stock is currently trading at $0.3 per share. It touched a 52-week high of $1.26 and a 52-week low of $1.26. Analysts tracking the stock have a 12-month average target price of $2.
Its 50-day moving average was $0.35 and 200-day moving average was $0.58 The short ratio stood at 2.42 indicating a short percent outstanding of 0%.
Around 290.7% of the company’s stock are held by insiders while 812.5% are held by institutions.
Frequently Asked Questions About Precipio Inc
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.